Hemogenyx Pharmaceuticals Plc (HEMO.L)

GBp 165.0

(-2.08%)

Total Liabilities Summary of Hemogenyx Pharmaceuticals Plc

Hemogenyx Pharmaceuticals Plc's latest annual total liabilities in 2023 was 3.32 Million GBP , down -13.62% from previous year.
Hemogenyx Pharmaceuticals Plc's latest quarterly total liabilities in 2024 Q2 was 3.09 Million GBP , down 0.0% from previous quarter.
Hemogenyx Pharmaceuticals Plc reported annual total liabilities of 3.84 Million GBP in 2022, up 990.88% from previous year.
Hemogenyx Pharmaceuticals Plc reported annual total liabilities of 352.84 Thousand GBP in 2021, down -80.28% from previous year.
Hemogenyx Pharmaceuticals Plc reported quarterly total liabilities of 3.09 Million GBP for 2024 Q1, down -6.98% from previous quarter.
Hemogenyx Pharmaceuticals Plc reported quarterly total liabilities of 3.59 Million GBP for 2023 Q2, down 0.0% from previous quarter.

Annual Total Liabilities Chart of Hemogenyx Pharmaceuticals Plc (2023 - 2014)

Historical Annual Total Liabilities of Hemogenyx Pharmaceuticals Plc (2023 - 2014)

Year	Total Liabilities	Total Liabilities Growth
2023	3.32 Million GBP	-13.62%
2022	3.84 Million GBP	990.88%
2021	352.84 Thousand GBP	-80.28%
2020	1.78 Million GBP	27.88%
2019	1.39 Million GBP	4.36%
2018	1.34 Million GBP	408.35%
2017	263.68 Thousand GBP	83.5%
2016	143.69 Thousand GBP	-41.78%
2015	246.83 Thousand GBP	0.0%
2014	- GBP	0.0%

Year	Total Liabilities	Total Liabilities Growth
2024 Q2	3.09 Million GBP	0.0%
2024 Q1	3.09 Million GBP	-6.98%
2023 Q2	3.59 Million GBP	0.0%
2023 Q4	3.32 Million GBP	0.0%
2023 Q3	3.32 Million GBP	-7.49%
2023 FY	3.32 Million GBP	-13.62%
2023 Q1	3.59 Million GBP	-6.63%
2022 Q1	963.16 Thousand GBP	172.97%
2022 Q4	3.84 Million GBP	0.0%
2022 Q2	963.16 Thousand GBP	0.0%
2022 FY	3.84 Million GBP	990.88%
2022 Q3	3.84 Million GBP	299.63%
2021 FY	352.84 Thousand GBP	-80.28%
2021 Q2	1.8 Million GBP	0.0%
2021 Q3	352.84 Thousand GBP	-80.43%
2021 Q4	352.84 Thousand GBP	0.0%
2021 Q1	1.8 Million GBP	0.79%
2020 Q3	1.78 Million GBP	-6.98%
2020 Q1	1.92 Million GBP	37.48%
2020 Q2	1.92 Million GBP	0.0%
2020 FY	1.78 Million GBP	27.88%
2020 Q4	1.78 Million GBP	0.0%
2019 Q1	1.26 Million GBP	-5.41%
2019 FY	1.39 Million GBP	4.36%
2019 Q2	1.26 Million GBP	0.0%
2019 Q4	1.39 Million GBP	0.0%
2019 Q3	1.39 Million GBP	10.34%
2018 Q2	295.96 Thousand GBP	4.49%
2018 Q1	283.25 Thousand GBP	7.42%
2018 Q3	1.34 Million GBP	352.91%
2018 Q4	1.34 Million GBP	0.0%
2018 FY	1.34 Million GBP	408.35%
2017 Q1	- GBP	-100.0%
2017 FY	263.68 Thousand GBP	83.5%
2017 Q2	218.1 Thousand GBP	0.0%
2017 Q3	263.68 Thousand GBP	20.9%
2017 Q4	263.68 Thousand GBP	0.0%
2016 FY	143.69 Thousand GBP	-41.78%
2016 Q4	143.69 Thousand GBP	0.0%
2016 Q2	95.4 Thousand GBP	0.0%
2015 FY	246.83 Thousand GBP	0.0%
2014 FY	- GBP	0.0%

Peer Total Liabilities Comparison of Hemogenyx Pharmaceuticals Plc

Name	Total Liabilities	Total Liabilities Difference